Question 1

What is Romosozumab used for?

Accepted Answer

Romosozumab (brand name Evenity) is a Sclerostin Inhibitor indicated for Osteoporosis (postmenopausal women at high fracture risk).

Question 2

How does Romosozumab work?

Accepted Answer

Romosozumab works through the following mechanism: Humanized monoclonal antibody that binds sclerostin, increasing bone formation and decreasing bone resorption simultaneously..

Question 3

What are the most common side effects of Romosozumab?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for Romosozumab. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is Romosozumab the same as Evenity?

Accepted Answer

Evenity is a brand name for Romosozumab. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

Romosozumab

Mechanism of Action

Indications

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations